Full-Time

Instrumentation and Controls Engineer

Updated on 9/3/2026

SHINE Technologies

SHINE Technologies

201-500 employees

Fusion-based neutron production for isotopes

Compensation Overview

$83k - $155.3k/yr

Janesville, WI, USA

Hybrid

Hybrid work arrangement will be considered.

Bachelor's

Category
Electrical Engineering (1)

Get referred to SHINE Technologies

See people who can refer or advise you

Requirements
  • A bachelor's degree or an equivalent combination of education and experience.
  • Knowledge of instrumentation and controls systems, hardware, software, theory of operation, environmental equipment, seismic qualification testing, and plant start-ups.
  • Experience finalizing specifications and design documents for vendor implementation on plant control systems and safety-related systems.
  • Ability to think strategically and take decisive action after gathering necessary information.
  • Ability to critically evaluate information and ask questions when information does not make sense.
  • Eligibility to qualify for access to information subject to U.S. export controls.
  • Eligibility may be conditioned on meeting Nuclear Regulatory Commission requirements for access to Safeguards Information, including pre-employment drug screening, fingerprinting, and a criminal background check.
  • Ability to perform the essential functions of the position, with reasonable accommodation where applicable.
Responsibilities
  • Lead interfaces between stakeholders and the instrumentation and controls team.
  • Provide input on the length and effort required for schedule tasks associated with creating design products.
  • Drive decisions on vendor requests, changes, and equipment and programming updates.
  • Serve as the responsible engineer for a subset of instrumentation and controls equipment through the design, procurement, and construction process while ensuring compliance with design requirements.
  • Oversee development of digital and analog control systems, including distributed control systems, programmable logic controllers, and data acquisition systems, by reviewing vendor deliverables.
  • Collaborate with other engineering disciplines to select instruments for measuring process variables in facility process systems.
  • Interface with the Auxiliary Systems Group to coordinate power distribution to instrumentation and controls equipment.
  • Prepare instrument specifications, calculations, and test plans for design, construction, testing, commissioning, in-field troubleshooting, and operation of the medical isotope production facility.
  • Design and implement instrument cable routing, conduit and raceway systems, installation drawings, and loop diagrams.
Desired Qualifications
  • Experience in nuclear analog and digital instrumentation, control, and monitoring.
  • Knowledge of nuclear safety-related systems, including NQA-1.
  • Understanding of appropriate cable shielding, cable type, radiation tolerance, and separation by safety train.

SHINE Technologies produces neutrons using fusion-based technology for practical applications in medicine, industry, and security. Its neutron source supports advanced industrial inspection and the production of medical isotopes used in diagnostic imaging and cancer treatment, as well as contraband detection. The neutron source operates through SHINE’s four-phase pathway to fusion energy production, enabling reliable, commercially viable neutron production rather than basic research. The company differentiates itself by focusing on immediate, real‑world deployments of fusion-based neutron production for diverse customers, guided by industry veterans on its board and a growth-oriented strategy to expand market applications. The goal is to commercialize fusion-powered neutron production to create safer, healthier, and cleaner outcomes while expanding its market reach in medical, industrial, and security sectors.

Company Size

201-500

Company Stage

Late Stage VC

Total Funding

$1.2B

Headquarters

Janesville, Wisconsin

Founded

2010

Get referred to SHINE Technologies

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • April 2026 DOE conditional commitment unlocked $263 million for Chrysalis completion.
  • August 2026 ARPA-E projects with GE Vernova, Argonne, and Case Western expand relevance.
  • June 2026 Newcleo partnership and European Ilumira approval broaden SHINE's commercial optionality.

What critics are saying

  • Chrysalis slipped from 2022 to 2029; completion risk persists despite April 2026 DOE financing.
  • The DOE loan remains conditional until technical, legal, environmental, and financial hurdles clear.
  • SHINE's 2023 cash-flow layoffs exposed financing fragility; another capital crunch could stall Chrysalis.

What makes SHINE Technologies unique

  • SHINE monetizes one platform across isotopes, neutron testing, and fuel recycling.
  • Chrysalis uses fusion-derived neutrons to produce Mo-99 domestically, reducing import dependence.
  • SHINE pairs NRC licensing experience with DOE-funded recycling collaborations like MAYER and PaCERS.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-2%

2 year growth

-2%
PR Newswire
Aug 18th, 2026
SHINE joins GE vernova-led ARPA-E project to modernize nuclear material accountability in fuel recycling.

SHINE joins GE vernova-led ARPA-E project to modernize nuclear material accountability in fuel recycling. Aug 18, 2026, 05:45 ET JANESVILLE, Wis., Aug. 18, 2026 /PRNewswire/ - As U.S. nuclear fuel recycling moves toward commercial reality, SHINE, a fusion energy company with a platform serving the nuclear fuel recycling market, is working with GE Vernova on a project to develop a modernized and more efficient system to track spent fuel throughout the recycling process. Led by GE Vernova's Advanced Research Center, the company's central technology development hub, the project - funded by the Department of Energy's Advanced Research Projects Agency-Energy (ARPA-E) program - aims to use artificial intelligence to optimize spent nuclear fuel tracking and measurement at recycling facilities. As a GE Vernova subcontractor, SHINE is developing improved sensor deployment and AI-powered material-tracking systems that would help incorporate material control and accountability into nuclear fuel recycling facilities from the very start. "There's a better way to handle material control and accountability at spent nuclear fuel recycling facilities - one that doesn't mean permanent cost and disruption," said Ross Radel, SHINE CTO. "As a company designing a recycling process of its own, SHINE is joining the GE Vernova-led collaboration to tackle the design challenge of building modern accountability and safeguards into nuclear recycling facilities from day one. Get that right, and these facilities will be more cost-effective and have less downtime." Economic viability is at the core of the project, which is developing technology known as Monochromatic Assays Yielding Enhanced Reliability, or MAYER, for spent nuclear fuel recycling facilities. The technology is intended to track and measure nuclear material in real time as it flows through a recycling facility and feed that information into a virtual digital twin, strengthening security safeguards while significantly reducing operating costs. Currently, nuclear operators may use redundant instrumentation, physical security measures, repeated manual sampling and periodic shutdowns to carry out inventory checks of nuclear material within a facility. Material control and accounting are part of a larger safeguards program run by the U.S. Nuclear Regulatory Commission to ensure nuclear material is not stolen or otherwise diverted. SHINE's work on the MAYER project supports its broader goal of building a commercial nuclear fuel recycling facility that would be classified in a lower-security NRC category, significantly reducing the physical security burden and cost. Along with the MAYER collaboration, SHINE announced today another partnership designed to pave the way for practical nuclear fuel recycling that turns nuclear "waste" into an energy resource. These technologies support the cost competitiveness SHINE is seeking in its Recover Elements - Destroy Undesirables - Create Energy nuclear fuel recycling process, called REDUCE for short. Together, they advance SHINE's work toward the first commercial application of advanced recycling technologies that aim to enable the efficient, proliferation-resistant extraction of uranium, plutonium and other high-value materials from spent nuclear fuel. About SHINE SHINE is a fusion energy company headquartered in Janesville, Wisconsin. We are leading the transition to the fusion economy through a vertically-integrated platform that supplies critical products to global markets, each one funding the next. Today, we supply defense and research customers with neutron-based testing. Our medical radioisotopes diagnose heart disease and treat cancer, and the world's largest commercial-scale medical isotope facility is now under construction. We are developing the technology to recycle used nuclear fuel, targeting a commercial pilot to draw down the 94,000 metric tons that have accumulated in the United States. Our long-term purpose is to put fusion energy on the grid. Learn more at www.shinefusion.com. About GE Vernova GE Vernova Inc. (NYSE: GEV) is a purpose-built global energy company that includes Power, Electrification, and Wind segments and is supported by its accelerator businesses. Building on over 130 years of experience tackling the world's challenges, GE Vernova is uniquely positioned to help lead the energy transition by continuing to electrify the world while simultaneously working to decarbonize it. GE Vernova helps customers power economies and deliver electricity that is vital to health, safety, security, and improved quality of life. GE Vernova is headquartered in Cambridge, Massachusetts, U.S., with approximately 85,000 employees across 100+ countries around the world. GE Vernova's Advanced Research segment is an innovation powerhouse, operating at the intersection of science and creativity to turn cutting edge research into impactful realities. Advanced Research collaborates with GE Vernova's businesses across a broad range of technical disciplines to accelerate the energy transition. SOURCE SHINE Technologies, LLC

Yahoo Finance
Aug 18th, 2026
SHINE joins GE Vernova ARPA-E project to modernise nuclear fuel recycling accountability with AI

SHINE is joining a GE Vernova-led project funded by the Department of Energy's Advanced Research Projects Agency-Energy to develop modernised nuclear material tracking systems for fuel recycling facilities. The project aims to use artificial intelligence to optimise spent nuclear fuel tracking and measurement. As a subcontractor, SHINE is developing improved sensor deployment and AI-powered material-tracking systems for nuclear fuel recycling facilities. The technology, called Monochromatic Assays Yielding Enhanced Reliability (MAYER), is designed to track and measure nuclear material in real time, feeding information into a virtual digital twin. The system aims to replace current methods involving redundant instrumentation, manual sampling, and periodic shutdowns for inventory checks. SHINE's participation supports its broader goal of building a commercial nuclear fuel recycling facility in a lower-security regulatory category.

SHINE Technologies
Aug 18th, 2026
SHINE to support Argonne National lab and Case Western Reserve University on high-throughput separation technology to advance nuclear fuel recycling.

SHINE to support Argonne National lab and Case Western Reserve University on high-throughput separation technology to advance nuclear fuel recycling. JANESVILLE, Wis., August 18, 2026 - SHINE, a fusion energy company with a platform serving the nuclear fuel recycling market, is collaborating with the Department of Energy's Argonne National Laboratory and Case Western Reserve University to apply chemical separation technology for the nuclear fuel recycling process SHINE is developing. The collaboration is being conducted through the Advanced Research Projects Agency-Energy (ARPA-E) CURIE Program, with additional funding, led by Case Western Reserve University, in which SHINE is participating as a subcontractor. Though frequently dubbed nuclear "waste," spent nuclear fuel retains some 90% of its energy potential, and its valuable byproducts have a variety of other uses as well. In recent years, federal initiatives and private investment have renewed interest in recycling spent nuclear fuel. To that end, Argonne is developing new chemical processing equipment known as Packed Centrifugal Equipment for Radiochemical Separation, or PaCERS, that spins fast enough to generate centrifugal forces beyond ordinary gravity to increase the efficiency of chemical separations. It's a high-throughput, lower-solvent approach to chemical separation that makes multiple stages of nuclear fuel recycling more economical. Through this collaboration, SHINE is working with Argonne and CWRU to apply the PaCERS technology to multiple separation processes, like those that separate the strontium-90 and americium-241 radioisotopes for use in medicine, manufacturing and advanced power systems. PaCERS technology will also be incorporated into the process for recovering minor actinides, long-lived radioactive material left over after other elements have been extracted. "Spent nuclear fuel is a tremendous resource, having many valuable materials that can be recovered instead of stored or even worse, disposed of. We already separate radioactive materials to produce medical isotopes today, and we're applying that same expertise to help push PaCERS toward practical use," said Ross Radel, CTO of SHINE. "It's another piece of the work we're doing to make nuclear energy effectively renewable." The transmutation of long-lived radioactive waste into a form that reduces its required isolation period from millennia to decades is part of SHINE's longer-term plan for nuclear waste mitigation. SHINE is currently validating how fusion-generated neutrons can transmute these long-lasting isotopes through another grant with DOE. Along with this collaboration involving Argonne and Case Western Reserve University, SHINE today announced participation on another project designed to pave the way for practical nuclear fuel recycling that turns "waste" into an energy resource. The project focuses on modernizing nuclear material control and accountability. These technologies support the cost competitiveness SHINE is seeking in its Recover Elements - Destroy Undesirables - Create Energy nuclear fuel recycling process, called REDUCE for short. Together, they advance SHINE's work toward the first commercial application of advanced recycling technologies that aim to enable the efficient, proliferation-resistant extraction of uranium, plutonium and other high-value materials from spent nuclear fuel. About Argonne Argonne National Laboratory seeks solutions to pressing national problems in science and technology by conducting leading-edge basic and applied research in virtually every scientific discipline. Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy's Office of Science. About Case Western Reserve University As one of the fastest-growing research universities in the United States, Case Western Reserve University is a force in career-defining education and life-changing research. Across its campus, more than 12,000 students from around the world converge to seek knowledge, find solutions and accelerate their impact. They learn from and collaborate with faculty members renowned for expertise in medicine, engineering, science, law, management, dental medicine, nursing, social work and the arts. And with its location in Cleveland - a hub of cultural, business and healthcare activity - its students gain unparalleled access to academic, research, clinical and entrepreneurial opportunities that prepare them to join its network of more than 125,000 alumni worldwide. Visit case.edu to see why Case Western Reserve University is built for those driven to be a force in the world. About SHINE SHINE is a fusion energy company headquartered in Janesville, Wisconsin. SHINE Technologies, LLC is leading the transition to the fusion economy through a vertically-integrated platform that supplies critical products to global markets, each one funding the next. Today, SHINE Technologies, LLC supply defense and research customers with neutron-based testing. Its medical radioisotopes diagnose heart disease and treat cancer, and the world's largest commercial-scale medical isotope facility is now under construction. SHINE Technologies, LLC is developing the technology to recycle used nuclear fuel, targeting a commercial pilot to draw down the 94,000 metric tons that have accumulated in the United States. Its long-term purpose is to put fusion energy on the grid. Learn more at www.shinefusion.com. Media Contact: [email protected]

World Nuclear News
Jun 18th, 2026
Shine, Newcleo join up to close nuclear fuel cycle.

Shine, Newcleo join up to close nuclear fuel cycle. Thursday, 18 June 2026 US fusion energy company Shine has joined a consortium that is working to build US nuclear fuel recycling capability. It has also agreed to work with France-based company Newcleo to link Shine's recycling capabilities with Newcleo's reactors, which are designed to run on recycled fuel. The MARIE (for Model for the Assessment of Reprocessing and Recycle with Innovative Execution) consortium is led by the independent non-profit EPRI research organisation and funded under the US Department of Energy's Advanced Research Projects Agency-Energy's (ARPA-E) CURIE programme. It is working to build an optimisation tool the US nuclear industry could use to evaluate and underwrite the first commercial used fuel recycling facilities. Shine is targeting a pilot facility capable of processing 100 tonnes of used nuclear fuel per year in the early 2030s - the kind of facility MARIE is designed to help underwrite. "Roughly 90,000 metric tonnes of used nuclear fuel sit in US storage today, and Shine's strategy is to turn that inventory into a strategic energy asset," the company said. Shine's role covers the security, regulatory, and commercial questions facing a US nuclear recycling industry, drawing on its experience in licensing its Chrysalis medical isotope production facility as well as its experience as a commercial isotope producer to assess the markets for valuable isotopes recoverable from used fuel. "Recycling effectively makes nuclear fuel a renewable resource, reshaping the next era of clean energy. The companies that figure out how to licence and build the facilities will set the pace for US recycling, and that's the work we're doing in this consortium," the company's founder and CEO Greg Piefer said. Technical collaboration In a separate announcement, Shine and Newcleo said they have agreed to collaborate on advancing innovative technologies for the recycling of used nuclear fuel. They will assess how Shine could supply Newcleo with materials from the used nuclear fuel of traditional reactors to manufacture MOX fuel, and how Shine could recycle spent fuel from Newcleo's reactors. The companies also intend to jointly pursue US federal funding opportunities and explore additional opportunities for collaboration across both the US and European Union, where they say used fuel stockpiles represent a growing strategic priority. Newcleo is developing advanced modular reactors cooled by liquid lead, and the facilities to produce mixed-oxide - or MOX - fuel to power them. Shine is developing nuclear fuel reprocessing technologies aimed at enabling the efficient and proliferation-resistant extraction of uranium and plutonium from existing used nuclear fuel inventories. The MOX fuel manufacturing capabilities that Newcleo is advancing can convert those materials into new fuel suitable for use in advanced reactor systems, the companies said. "Closing the fuel cycle will require deep, industry-wide collaboration that brings together expertise from across the nuclear fuel supply chain. Today marks an important step in that direction, combining Shine's recycling capabilities with Newcleo's advanced fuel manufacturing and reactor technologies," Newcleo founder and CEO Stefano Buono said. "Recycling spent nuclear fuel solves two problems at once. It addresses decades of accumulated waste and removes the fuel supply constraint on expanding the reactor fleet. Working with Newcleo connects our capabilities directly to reactors designed to run on recycled fuel. That closed fuel cycle effectively makes nuclear energy renewable and fundamentally changes its economics," Piefer said. The companies plan to begin technical scoping this year, with joint federal funding proposals to follow. Last year, Newcleo signed an agreement with US-based sodium-cooled fast-reactor developer Oklo to develop advanced fuel fabrication and manufacturing infrastructure in the USA. It has begun pre-application engagement with the US Nuclear Regulatory Commission to support the future licensing of its first Lead-cooled Fast Reactor and an associated MOX fuel fabrication facility.

PR Newswire
May 29th, 2026
SHINE's Ilumira gains European approval, expands nuclear medicine platform with $269M funding

SHINE Technologies has secured European marketing authorisation for Ilumira, its non-carrier-added lutetium-177 (Lu-177), opening a major market for the radioisotope used in targeted cancer therapy. The approval allows SHINE to sell Lu-177 across the European Union. The Wisconsin-based company is building an integrated nuclear medicine platform spanning diagnostic and therapeutic radioisotopes. In January, SHINE acquired a US isotope manufacturing facility, adding diagnostic products including Tc-99m generators and cardiac imaging agents used in millions of procedures annually. Recent milestones include a $240 million Series E funding round led by Dr Patrick Soon-Shiong in February and a $263 million conditional loan commitment from the US Department of Energy in April to complete its Chrysalis facility, designed to become the world's largest medical isotope production site.